You have 9 free searches left this month | for more free features.

BMN165

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Phenylketonuria (PKU) Trial in United States (BMN165 20mg/day, BMN165 40mg/day, Placebo)

Completed
  • Phenylketonuria (PKU)
  • BMN165 20mg/day
  • +2 more
  • La Jolla, California
  • +28 more
Apr 29, 2021

Phenylketonuria (PKU) Trial in Germany, United States (Pegvaliase, Diet Only)

Recruiting
  • Phenylketonuria (PKU)
  • Little Rock, Arkansas
  • +18 more
Aug 8, 2022

Phenylketonuria Trial in United States (BMN 165 (rAvPAL-PEG))

Completed
  • Phenylketonuria
  • BMN 165 (rAvPAL-PEG)
  • Aurora, Colorado
  • +5 more
Jul 23, 2019

Phenylketonuria Trial in United States (BMN 165)

Completed
  • Phenylketonuria
  • BMN 165
  • La Jolla, California
  • +30 more
Feb 6, 2019

A Phase 3 Substudy to Evaluate Executive Function in PKU Who Are

Completed
  • Phenylketonuria
  • Administration of CANTAB and Subject Global Assessment
  • Lexington, Kentucky
  • +3 more
May 21, 2020

Phenylketonuria Trial in United States (rAvPAL-PEG)

Completed
  • Phenylketonuria
  • Aurora, Colorado
  • +8 more
Feb 4, 2019

Phenylketonuria Trial in United States (rAvPAL-PEG 0.001 mg/kg, rAvPAL-PEG 0.003 mg/kg, rAvPAL-PEG 0.01 mg/kg)

Completed
  • Phenylketonuria
  • rAvPAL-PEG 0.001 mg/kg
  • +4 more
  • Aurora, Colorado
  • +10 more
Feb 4, 2019

Late-onset Pompe Disease Trial in Worldwide (BMN 701)

Terminated
  • Late-onset Pompe Disease
  • BMN 701
  • Phoenix, Arizona
  • +21 more
Jun 12, 2018